Want to join the conversation?
Pharma company $MRK said the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has expressed positive opinion of KEYTRUDA used for treating metastatic non-small cell lung cancer in adults whose tumors express PD-L1 and who have received at least one chemotherapy regimen.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.